GSK to stop paying doctors to promote drugs

Tags: Drugs, GSK, News
GlaxoSmithKline Plc will stop paying doctors to promote its products, Chief Executive Andrew Witty said in an interview with the New York Times, in a move that could be a first for a major drug company.

GSK will also stop tying compensation of sales representatives to the number of prescriptions doctors write, the NY Times said.

The company's decision comes at a time when GSK faces allegations of illegal payments to Chinese doctors and officials.

Chinese police have accused GSK of funneling up to 3 billion yuan to travel agencies to facilitate bribes to boost its drug sales. The accusations are the most serious against a multinational in China in years.

However, in the interview Witty said that the proposed changes were unrelated to the investigation in China, and are part of a yearslong effort "to try and make sure we stay in step with how the world is changing."

Witty declined to comment to the newspaper on the Chinese investigation because he said it was still underway.

GlaxoSmithKline could not immediately be reached for comment by Reuters outside of business hours.

Post new comment

E-mail ID will not be published
This question is for testing whether you are a human visitor and to prevent automated spam submissions.


  • The economic survey falls in step with the BJP’s election manifesto

    It’s always tough to find something wrong with the annual economic survey as it only articulates the government’s desire to set its house in order


Stay informed on our latest news!


GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India


Arun Nigavekar

Why higher education needs innovation

India is such a great country that it creates complexity ...

Zehra Naqvi

We must overcome the fear of death

It is the biggest irony that the only thing that’s ...

Dharmendra Khandal

Jawai leopards and locals can coexist peacefully

At first glance, the Jawai landscape seems like a large ...


William D. Green

Chairman & CEO, Accenture